Clinical trialNCT03670641CompletedPhase 4Interventional

Remission Through Early Monitored Insulin Therapy - Duration Month

SponsorSandra SobelEnrollment10Type 2 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

REMIT-DM is a feasibility pilot study where participants will be recruited soon after their diagnosis of type 2 diabetes to be placed immediately on insulin therapy for maximum of four weeks with titrations of insulin guided by glucose levels and trends provided by a continuous glucose monitor (CGM), with the purpose of achieving diabetes remission.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

David A Rometo, MD
University of Pittsburgh
Principal Investigator
clinicaltrials.gov ↗
Linda Siminerio, RN PhD
University of Pittsburgh
Principal Investigator
clinicaltrials.gov ↗
Sandra I Sobel, MD
University of Pittsburgh
Principal Investigator
clinicaltrials.gov ↗
Shari Reynolds
University of Pittsburgh
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Upmc Falk Diabetes Clinic
Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GlargineLispro

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 26 Mar 2019
Primary completion: 31 Jul 2020
Completion: 31 Jul 2020
Last update posted: 12 Oct 2021
Registered enrollment: 10
Registry id: NCT03670641

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.